Keyphrases
Estrogen Receptor
100%
Human Keratinocytes (HaCaT)
100%
Estrogen
100%
Healing
100%
Differential Involvement
100%
Promoting Effect
100%
Diarylpropionitrile
50%
Cell Migration
37%
Wound Closure
25%
Cell Proliferation
25%
TGF-1
25%
Mechanism of Action
12%
P-hydroxyphenyl
12%
Receptor Antagonist
12%
Receptor Subtypes
12%
Bromodeoxyuridine
12%
Wound Healing
12%
Western Blot Analysis
12%
Propyl
12%
Long-term Treatment
12%
Scratch Test
12%
17-estradiol
12%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
12%
Immunohistochemical Analysis
12%
1H-pyrazole
12%
Tris
12%
Estradiol-17
12%
Transforming Growth Factor-β
12%
A1 Receptor
12%
Selective Agonist
12%
Wound Healing Process
12%
Selective Activation
12%
In Vivo Wound Healing
12%
Long-term Exposure
12%
U0126
12%
Mitogen-activated Protein Kinase Inhibitor
12%
Extranuclear
12%
Transwell Migration Assay
12%
SB431542
12%
Accelerating Cell
12%
Skin Components
12%
Human Keratinocyte Cell Line
12%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Diarylpropionitrile
50%
Wound
37%
Wound Healing
37%
Receptor Antagonist
12%
Diethylstilbestrol
12%
Prevalence
12%
Broxuridine
12%
Western Blot
12%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
12%
Receptor Subtype
12%
Fibrinogen
12%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
12%
Long Term Exposure
12%
Mitogen Activated Protein Kinase Inhibitor
12%
1,3,5 Tris(4 Hydroxyphenyl) 4 Propylpyrazole
12%
4 [4 (1,3 Benzodioxol 5 Yl) 5 (2 Pyridinyl) 1h Imidazol 2 Yl]benzamide
12%
Cancer Growth Factor
12%